Novel method of whole lung lavage therapy using biphasic cuirass ventilator for pulmonary alveolar proteinosis; the retrospective observational study.

d. tamanoi (kumamoto-shi, Japan), C. Yoshida (kumamoto-shi, Japan), T. Kimura (kumamoto-shi, Japan), T. Jodai (kumamoto-shi, Japan), T. Isimura (kumamoto-shi, Japan), S. Okamoto (kumamoto-shi, Japan), H. Ichiyasu (kumamoto-shi, Japan), T. Yamamoto (kumamoto-shi, Japan), T. Sakagami (kumamoto-shi, Japan)

Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
d. tamanoi (kumamoto-shi, Japan), C. Yoshida (kumamoto-shi, Japan), T. Kimura (kumamoto-shi, Japan), T. Jodai (kumamoto-shi, Japan), T. Isimura (kumamoto-shi, Japan), S. Okamoto (kumamoto-shi, Japan), H. Ichiyasu (kumamoto-shi, Japan), T. Yamamoto (kumamoto-shi, Japan), T. Sakagami (kumamoto-shi, Japan). Novel method of whole lung lavage therapy using biphasic cuirass ventilator for pulmonary alveolar proteinosis; the retrospective observational study.. 3407

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Whole lung lavage with intermittent double lung ventilation: a new technique for managing pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 91s
Year: 2004

Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis
Source: Eur Respir J 2012; 39: 1049
Year: 2012


Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 526-531
Year: 2004



Efficacy of total lung lavage in pulmonary alveolar proteinosis: A multicenter international study of GELF
Source: International Congress 2016 – Advancements in bronchoscopy
Year: 2016


An open-label trial of rituximab therapy in pulmonary alveolar proteinosis
Source: Eur Respir J 2011; 38: 1361-1367
Year: 2011



Pulmonary alveolar proteinosis therapy success with combined lavage procedures: a case report
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009


Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004

Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 220s
Year: 2001

Whole lung lavage therapy (WLL) of pulmonary alveolar proteinosis (PAP): A global survey of current practices and procedures
Source: International Congress 2016 – Orphan diseases I
Year: 2016

The benefits of whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 503-505
Year: 2004


Outpatient lobar lavage: a novel approach to managing pulmonary alveolar proteinosis
Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches
Year: 2020


Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study
Source: International Congress 2015 – IIPs: orphan
Year: 2015

Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report
Source: Eur Respir J 2003; 22: Suppl. 45, 44s
Year: 2003

Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009



Secondary pulmonary alveolar proteinosis after lung transplantation: a single-centre series
Source: Eur Respir J , 49 (2) 1601369; DOI: 10.1183/13993003.01369-2016
Year: 2017


Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage
Source: International Congress 2017 – Paediatric bronchology
Year: 2017

Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child
Source: Eur Respir J 2003; 22: Suppl. 45, 309s
Year: 2003

Long-term non-invasive ventilation (NIV) in adults with cystic fibrosis (CF): a retrospective study
Source: Eur Respir J 2004; 24: Suppl. 48, 544s
Year: 2004

Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006